Search results for " Rating"

showing 10 items of 529 documents

Is interpersonal counselling (IPC) sufficient treatment for depression in primary care patients? A pilot study comparing IPC and interpersonal psycho…

2015

Abstract Background Psychotherapeutic treatment is underused in primary care, where even short-term psychotherapy can be perceived as too lengthy and labour-intensive. We tested here for the first time the preliminary efficacy of seven sessions of interpersonal counselling (IPC) by comparison with sixteen sessions of interpersonal psychotherapy (IPT) in regular clinical settings. Methods Patients seeking treatment for the first time who met the DSM-IV criteria for major depressive disorder (MDD, mild/moderate) were randomized to either IPC ( n =20) or IPT ( n =20). The efficacy of the treatments was assessed using the 34-item Clinical Outcomes in Routine Evaluation (CORE-OM) scale and the B…

AdultCounselingMale050103 clinical psychologyvuorovaikutusterapiamedicine.medical_treatmentPilot ProjectsPrimary careInterpersonal communication03 medical and health sciencesprimary care0302 clinical medicineIntervention (counseling)parasitic diseasesmedicineinterpersonal counsellingHumans0501 psychology and cognitive sciencesta515Depression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorPrimary Health CareCORE-OM05 social sciencesBeck Depression Inventorymedicine.diseaseta3124030227 psychiatryClinical trialPsychiatry and Mental healthClinical PsychologyTreatment Outcomeinterpersonal therapydepressionInterpersonal psychotherapyIPCPsychotherapy BriefMajor depressive disorderFemalePsychologyClinical psychology
researchProduct

Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.

2004

Background This study evaluated the serotonergic antidepressant nefazodone versus placebo and specific cognitive-behavioral therapy (CBT) versus nondirective group counseling (GC) for relapse prevention in alcohol dependence in a large prospective, randomized, and placebo-controlled double-blind study at 3 German university centers. Method 242 male patients fulfilling at least 5 criteria for alcohol dependence according to DSM-IV and ICD-10 were eligible, after detoxification, for one of the following treatment combinations: nefazodone + CBT, nefazodone + GC, placebo + CBT, and placebo + GC. Either nefazodone or placebo was administered throughout the evaluation period of 15 months. Either …

AdultCounselingMalemedicine.medical_specialtymedicine.medical_treatmentRelapse preventionPlaceboPiperazineslaw.inventionGroup psychotherapyPlacebosRandomized controlled triallawInternal medicinemedicineSecondary PreventionHumansDiagnosis Computer-AssistedPsychiatryPsychiatric Status Rating ScalesCognitive Behavioral TherapyAlcohol dependenceTriazolesCombined Modality TherapyClinical trialCognitive behavioral therapyPsychiatry and Mental healthAlcoholismTreatment OutcomePsychologyNefazodonemedicine.drugThe Journal of clinical psychiatry
researchProduct

Brief assessment of schizotypal traits: A multinational study

2018

The Schizotypal Personality Questionnaire-Brief (SPQ-B) was developed with the aim of examining variations in healthy trait schizotypy, as well as latent vulnerability to psychotic-spectrum disorders. No previous study has studied the cross-cultural validity of the SPQ-B in a large cross-national sample. The main goal of the present study was to analyze the reliability and the internal structure of SPQ-B scores in a multinational sample of 28,426 participants recruited from 14 countries. The mean age was 22.63. years (SD = 7.08; range 16-68. years), 37.7% (n = 10,711) were men. The omega coefficients were high, ranging from 0.86 to 0.92 for the total sample. Confirmatory factor analysis rev…

AdultCross-Cultural ComparisonMaleAdolescentPersonality InventoryPsychometricsSchizotypymedia_common.quotation_subjectSPQ-BCross-cultural; Psychosis; Psychosis risk; Schizotypal personality; Schizotypy; SPQ-BSample (statistics)Interpersonal communicationDevelopmental psychologySchizotypal Personality Disorder03 medical and health sciencesYoung AdultSchizotypy0302 clinical medicinePersonalityHumansMeasurement invariancePsychosis riskBiological Psychiatrymedia_commonAgedPsychiatric Status Rating ScalesSchizotypal personalityReproducibility of ResultsCross-culturalMiddle AgedPsychosisMental healthConfirmatory factor analysis030227 psychiatryPsychiatry and Mental healthTraitFemalePsychologyFactor Analysis Statistical030217 neurology & neurosurgery
researchProduct

The influence of family expressed emotion on the course of schizophrenia in a sample of Spanish patients. A two-year follow-up study.

1992

A sample of 60 Spanish schizophrenic patients was studied to ascertain the relationship between their relatives' expressed emotion (EE) and relapse at follow-up. The relatives' EE and patients' relapse were operationalised following Leff & Vaughn's criteria. At nine months a significant association was not found between the relatives' EE and relapse, but this association became significant on reclassifying the relatives' EE scores after decreasing to four points the cut-off point for critical comments. At 24 months no association was found between EE and relapse. There was a tendency for patients who interrupted their medication or who did not work to relapse more frequently, particular…

AdultCross-Cultural ComparisonMalePsychosismedicine.medical_specialtyEmotionsSocial Environment03 medical and health sciences0302 clinical medicineHostilityRecurrencemedicineExpressed emotionHumansFamily030212 general & internal medicinePsychiatryPsychiatric Status Rating ScalesFollow up studiesmedicine.disease030227 psychiatryPsychiatry and Mental healthCaregiversSchizophreniaSpainSchizophreniaFemaleSchizophrenic PsychologyPsychologyFollow-Up StudiesThe British journal of psychiatry : the journal of mental science
researchProduct

The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted…

1994

This report from the WHO project on Psychological Problems in General Health Care examines the relevance in primary care of the concept of recurrent brief depression (RBD) proposed by Jules Angst. RBD refers to brief, severe depressive episodes that recur frequently, i.e. nearly once a month over, a 1-year period, according to Angst. Using a structured interview (CIDI), RBD was assessed in patients not meeting the criteria for depressive episodes lasting at least 2 weeks, as defined in the ICD-10 (DE). A substantial proportion of primary care seekers were identified as presenting RBD without other depressive disorders, 3.7% with a formal RBD diagnosis and 2.7% with frequent but not monthly …

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricsPoison controlSuicide AttemptedComorbidityWorld Health OrganizationSuicide preventionOccupational safety and healthRecurrent brief depressionRecurrenceInjury preventionmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderPrimary Health Carebusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaseCIDIComorbidityPsychiatry and Mental healthCross-Sectional StudiesFemalebusinessEuropean archives of psychiatry and clinical neuroscience
researchProduct

Emotion recognition, emotional awareness and cognitive bias in individuals with bulimia nervosa

2008

Difficulties recognizing emotion have been reported for eating disordered individuals in relation to perception of emotions in others and emotional self-awareness. It remains unclear whether this is a perceptual or cognitive-affective problem. Clarification is sought and the question of a cognitive bias is addressed when interpreting facially expressed emotions. Twenty participants with bulimia nervosa (BN) and 20 normal controls (NC) were assessed for ability to recognize emotional and neutral expressions. Emotional self-awareness was also assessed. Significant differences were found for emotional self-awareness. For emotional faces, only a poorer recognition of the emotion, surprise, for …

AdultEmotion classificationEmotionsEmotional contagionDevelopmental psychologyPerceptual DisordersArts and Humanities (miscellaneous)Surveys and QuestionnairesTask Performance and AnalysismedicineHumansExpressed emotionEmotional expressionBulimia NervosaPsychiatric Status Rating ScalesBulimia nervosaRecognition PsychologyCognitionAwarenessmedicine.diseaseControl GroupsSelf ConceptCognitive biasFacial ExpressionClinical PsychologyEating disordersPattern Recognition VisualSocial PerceptionVisual PerceptionFemaleCognition DisordersPsychologyJournal of Clinical Psychology
researchProduct

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.

1994

Single photon emission tomography (SPECT) imaging of the central benzodiazepine receptor (BZr) became possible with the newly developed ligand 123I-IOMAZENIL. The BZr binding was investigated in ten patients with panic disorder (PP) compared to ten epileptic patients (EP). Panic patients had lower IOMAZENIL uptake rates in the frontal, occipital and temporal cortex than EP indicating the involvement of the BZr complex in panic disorder.

AdultFlumazenilMalemedicine.medical_specialtymedicine.drug_classbehavioral disciplines and activitiesCerebral VentriclesInternal medicinemental disordersmedicineHumansPharmacology (medical)Biological PsychiatryBenzodiazepine receptor bindingTemporal cortexPsychiatric Status Rating ScalesTomography Emission-Computed Single-PhotonIomazenilBenzodiazepinePanic disorderPanicGeneral Medicinemedicine.diseaseReceptors GABA-AFrontal LobePsychiatry and Mental healthEndocrinologyFlumazenilAnesthesiaPanic DisorderFemaleOccipital Lobemedicine.symptomPsychologyAnxiety disordermedicine.drugEuropean archives of psychiatry and clinical neuroscience
researchProduct

Association analysis of SCN9A gene variants with borderline personality disorder

2008

Borderline personality disorder (BPD) is a serious psychiatric disorder affecting about 1-2% of the general population. Key features of BPD are emotional instability, strong impulsivity, repeated self-injurious behavior (SIB) and dissociation. In the etiology of BPD and its predominant symptoms, genetic factors have been suggested. The voltage-gated sodium channel Nav1.7 is expressed in sensory neurons and in the hippocampus, a key region of the limbic system probably dysfunctional in BPD and dissociative disorders. The alpha-subunit of Nav1.7 is encoded by the SCN9A gene on chromosome 2 and variations of SCN9A can lead to complete inability to sense pain. The aim of the present study was t…

AdultGenetic MarkersMaleOncologyCandidate genemedicine.medical_specialtyPopulationSingle-nucleotide polymorphismImpulsivityPolymorphism Single Nucleotidebehavioral disciplines and activitiesBorderline Personality DisorderInternal medicinemental disordersmedicineHumansDissociative disordersSex DistributioneducationBorderline personality disorderBiological PsychiatryGenetic associationPsychiatric Status Rating ScalesGeneticseducation.field_of_studymedicine.diseasePsychiatry and Mental healthHaplotypesCase-Control StudiesFemaleSCN9A Genemedicine.symptomPsychologyJournal of Psychiatric Research
researchProduct

Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: A pilot study

2011

Some renal transplant patients show cognitive, emotional, and behavioral changes as part of possible neurotoxic effects associated with immunosuppressive medication, especially tacrolimus. This study evaluated effects of immunosuppressive drugs on some cognitive tasks. Patients treated with sirolimus and cyclosporine reported some of the noncognitive side effects related to immunosuppressive treatment. We observed attention and working memory impairment in patients treated with sirolimus or tacrolimus. Performance of cyclosporine-treated subjects was similar to that of healthy volunteer controls. Since the mood, anxiety, and sleep patterns measured were unaffected, it could be concluded tha…

AdultGraft RejectionMaleSleep Wake Disordersmedicine.medical_specialtyPilot ProjectsNeuropsychological TestsDevelopmental psychologyYoung AdultSurveys and QuestionnairesInternal medicinemedicineHumansNeuropsychological assessmentCognitive deficitPsychiatric Status Rating ScalesAnalysis of Variancemedicine.diagnostic_testCognitionMiddle AgedKidney TransplantationTacrolimusTransplantationClinical Psychologysurgical procedures operativeMoodNeurologySirolimusQuality of LifeKidney Failure ChronicAnxietyFemaleNeurology (clinical)medicine.symptomCognition DisordersPsychologyImmunosuppressive AgentsFollow-Up Studiesmedicine.drugJournal of Clinical and Experimental Neuropsychology
researchProduct

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1994

Summary Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic Study. Side effects that worsened over baseline to a greater extent with alprazolam than with imipramine and placebo were sedation, fatigue/weakness, memory problems, ataxia and slurred speech…

AdultImipramineAdolescentSide effectPoison controlPlaceboImipramineDouble-Blind MethodmedicineHumansPharmacology (medical)Biological PsychiatryAgedPsychiatric Status Rating ScalesPharmacologyAlprazolambusiness.industryPanic disorderPanicMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyAlprazolamAnesthesiaPanic DisorderPatient ComplianceNeurology (clinical)medicine.symptombusinessAgoraphobiamedicine.drugEuropean Neuropsychopharmacology
researchProduct